MDM2 and atypical lipomatous tumor: MDM2 amplification is detected in nearly all atypical lipomatous tumors (ALT), well-differentiated liposarcomas (WDL), and dedifferentiated liposarcomas, and is regarded as the driver gene of these tumors (19, 20).